Hoth Therapeutics Announces Positive Preliminary, Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease
Stock Information for Hoth Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.